H7N6 highly pathogenic avian influenza in Mozambique, 2023.

On 13 October 2023, the National Directorate for Livestock Development in Mozambique was notified of a suspected outbreak of avian influenza in commercial layers. Samples were screened by real-time and conventional RT-PCR and were positive for both H7 and N6. Full genome sequences were obtained for three representative samples. Sequence analysis of the H7 cleavage site confirmed that the viruses were highly pathogenic (i.e. 333- PEPPKGPRFRR/GLF-346). In addition, the H7 and N6 sequences were highly similar (from 99.4-99.5% and 99.6-99.7% for the HA gene and the NA gene, respectively) to the sequences of a H7N6 virus identified in the Republic of South Africa in May 2023 indicating a similar origin of the viruses. The identification of H7N6 HPAIV in Mozambique has important implications for disease management and food security in the region.

Peste des Petits Ruminants Virus Surveillance in Domestic Small Ruminants, Mozambique (2015 and 2017).

Peste des Petits Ruminants (PPR), a transboundary animal disease affecting mainly goats and sheep is caused by a morbillivirus and threatens food security and livelihoods as morbidity and mortality rates can reach 90%. There are no records of PPR in Mozambique, but the disease situation in Tanzania and the ability of PPR virus to rapidly spread across countries constitute a high risk for about 4.7 million goats and sheep in Mozambique. A total of 4,995 goats and sheep were sampled in several provinces during 2015 and 2017 to assess the status of PPR virus (PPRV) in Mozambique and to contribute to surveillance along the border with Tanzania. The sera were screened for anti-PPRV antibodies using a commercial PPR competition ELISA (c-ELISA) and the haemagglutinin based PPR blocking ELISA (HPPR-bELISA). The swabs were tested using one-step RT-PCR for detection of PPRV RNA. The overall percentage of animals with anti-PPRV antibodies by c-ELISA, was 0.46% [0.30-0.70]. However, all the sera positive on c-ELISA were confirmed to be negative by the HPPR-bELISA. Considering that all the swabs were negative for detection of PPRV, no clinical cases were observed during passive surveillance and active sampling, and no symptoms were reported, these results suggest that PPRV is not present in Mozambique.